Published in Am J Epidemiol on December 15, 1995
A Program on Prevention of Mother to Child Transmission of HIV at Government Hospital, Tiruchengode Taluk, Namakkal District. Indian J Community Med (2009) 2.26
Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One (2015) 2.02
The standard of care debate: can research in developing countries be both ethical and responsive to those countries' health needs? Am J Public Health (2004) 1.88
Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding. J Virol (2008) 1.44
Human immunodeficiency virus-related mortality in infants and children: data from the pediatric pulmonary and cardiovascular complications of vertically transmitted HIV (P(2)C(2)) Study. Pediatrics (2001) 1.44
Early antenatal care: does it make a difference to outcomes of pregnancy associated with syphilis? A systematic review and meta-analysis. PLoS One (2013) 1.28
Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France. Clin Exp Immunol (2007) 1.19
Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease. J Virol (1997) 1.10
Mother-to-child transmission of human immunodeficiency virus type 1. Epidemiol Rev (1996) 1.08
British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998). Sex Transm Infect (1999) 1.05
HIV-1 co-receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV-1 primary isolates. Clin Exp Immunol (2000) 1.04
Beyond prevention of mother-to-child transmission: keeping HIV-exposed and HIV-positive children healthy and alive. AIDS (2013) 1.02
CCR5 haplotypes and mother-to-child HIV transmission in Malawi. PLoS One (2007) 0.99
Human trophoblasts confer resistance to viruses implicated in perinatal infection. Am J Obstet Gynecol (2014) 0.96
Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. P2C2 HIV Study Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland. J Am Coll Cardiol (1998) 0.92
Cost-effectiveness of Childbirth Strategies for Prevention of Mother-to-child Transmission of HIV Among Mothers Receiving Nevirapine in India. Indian J Community Med (2010) 0.89
Factors associated with HIV infection among children born to mothers on the prevention of mother to child transmission programme at Chitungwiza Hospital, Zimbabwe, 2008. BMC Public Health (2013) 0.87
Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome. Retrovirology (2009) 0.86
Estimating the timing of mother-to-child transmission of the human immunodeficiency virus type 1 using a viral molecular evolution model. PLoS One (2014) 0.83
Acceptability of perinatal rapid point-of-care HIV testing in an area of low HIV prevalence in the UK. Arch Dis Child (2007) 0.83
Materno-fetal transmission of human immune deficiency virus. Infect Dis Obstet Gynecol (1997) 0.79
Maternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective study. Virol J (2005) 0.76
Universal children's day--let's improve current interventions to reduce vertical transmission of HIV now. J Int AIDS Soc (2014) 0.75
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science (1984) 10.38
A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat Med (2004) 5.90
Understanding the dynamics of Ebola epidemics. Epidemiol Infect (2006) 5.81
A computer network for the surveillance of communicable diseases: the French experiment. Am J Public Health (1986) 5.38
Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med (1996) 5.36
The gut-associated lymphoid system: nature and properties of the large dividing cells. Eur J Immunol (1974) 4.76
The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions. J Exp Med (1978) 4.57
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet (1999) 4.20
A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N Engl J Med (1989) 3.98
Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med (2000) 3.95
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol (1987) 3.30
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet (2003) 3.23
Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell (1988) 3.09
Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet (1989) 2.98
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis (2001) 2.95
Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet (1997) 2.93
Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS (1998) 2.90
Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic. J Epidemiol Community Health (1998) 2.86
What is known about the prevention of congenital toxoplasmosis? Lancet (1990) 2.78
Epidemiologic mapping using the "kriging" method: application to an influenza-like illness epidemic in France. Am J Epidemiol (1992) 2.76
Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest (1997) 2.76
The distribution of large dividing lymph node cells in syngeneic recipient rats after intravenous injection. J Exp Med (1969) 2.76
Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med (1982) 2.73
Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis (1997) 2.72
Modelling the 1985 influenza epidemic in France. Stat Med (1988) 2.70
The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. The HIV Infection in Newborns French Collaborative Study Group. N Engl J Med (1992) 2.66
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA (2001) 2.63
A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol Suppl (1987) 2.62
Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis (1999) 2.49
Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest (1990) 2.46
Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction. Lancet (1988) 2.43
Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics (1994) 2.33
Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet (1984) 2.32
Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child (1990) 2.30
CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group. JAMA (1998) 2.25
Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr (1989) 2.22
A syndrome associating partial albinism and immunodeficiency. Am J Med (1978) 2.19
A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature (1985) 2.16
Modeling the spread of resistant nosocomial pathogens in an intensive-care unit. Infect Control Hosp Epidemiol (1997) 2.16
Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbiol (1991) 2.16
Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia (1996) 2.15
Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Pediatrics (1996) 2.14
Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. AIDS (2000) 2.14
Patterns of disclosure and perceptions of the human immunodeficiency virus in infected elementary school-age children. Arch Pediatr Adolesc Med (1997) 2.14
PENTA guidelines for the use of antiretroviral therapy, 2004. HIV Med (2004) 2.10
Immunological conditions of children with BCG disseminated infection. Lancet (1995) 2.05
Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group. AIDS (2000) 2.04
Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis. J Clin Invest (1978) 2.03
Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA (1998) 2.01
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood (2001) 1.98
Virtual surveillance of communicable diseases: a 20-year experience in France. Stat Methods Med Res (2006) 1.98
Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet (2000) 1.98
Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis (1997) 1.96
Sentiweb: French communicable disease surveillance on the World Wide Web. BMJ (1996) 1.94
Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA (1996) 1.94
A routine tool for detection and assessment of epidemics of influenza-like syndromes in France. Am J Public Health (1991) 1.90
Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol (1992) 1.89
Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med (1994) 1.85
Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr (1993) 1.81
CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology (2012) 1.80
Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation. J Pediatr (1981) 1.79
Intraepithelial lymphocytes of human gut: isolation, characterisation and study of natural killer activity. Gut (1985) 1.76
Computer networking as a tool for public health surveillance: the French experiment. MMWR Morb Mortal Wkly Rep (1992) 1.75
Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.74
Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr (1999) 1.73
Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet (1993) 1.72
Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer (1984) 1.71
Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet (1985) 1.70
Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science (2000) 1.70
Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis (2001) 1.68
Sentinelle traces of an epidemic of acute gastroenteritis in France. Lancet (1995) 1.67
The French Communicable Diseases Computer Network. A seven-year experiment. Ann N Y Acad Sci (1992) 1.66
A mathematical model for the European spread of influenza. Eur J Epidemiol (1994) 1.64
Controlled clinical trial of homoeopathy in postoperative ileus. Lancet (1988) 1.61
Modeling the hepatitis C virus epidemic in France. Hepatology (1999) 1.61
Specific protease deficiency in polymorphonuclear leukocytes of Chédiak-Higashi syndrome and beige mice. J Exp Med (1978) 1.60
Trends in primary liver cancer. Lancet (1998) 1.56
Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Clin Pharmacol Ther (2008) 1.56
Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity. J Immunol (1981) 1.55
Semen characteristics as a function of age in 833 fertile men. Fertil Steril (1983) 1.49
Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood (1997) 1.49
Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol (1997) 1.47
Immunoglobulins on the surface of lymphocytes in fifty patients with primary immunodeficiency diseases. Clin Immunol Immunopathol (1973) 1.46
A mathematical model for evaluating the impact of vaccination schedules: application to Neisseria meningitidis. Epidemiol Infect (2003) 1.46